Table of Contents

2019-2024 Global Oncolytic Virus Therapy Market Report (Status and Outlook)

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncolytic Virus Therapy Market Size 2014-2024
2.1.2 Oncolytic Virus Therapy Market Size CAGR by Region
2.2 Oncolytic Virus Therapy Segment by Type
2.2.1 HSV-based Oncolytic Viruses
2.2.2 Adenoviruses-based Oncolytic Viruses
2.2.3 Vaccinia Virus-based Oncolytic Viruses
2.2.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
2.2.5 Newcastle Disease Virus-based Oncolytic Viruses
2.3 Oncolytic Virus Therapy Market Size by Type
2.3.1 Global Oncolytic Virus Therapy Market Size Market Share by Type (2014-2019)
2.3.2 Global Oncolytic Virus Therapy Market Size Growth Rate by Type (2014-2019)
2.4 Oncolytic Virus Therapy Segment by Application
2.4.1 Melanoma
2.4.2 Prostate?Cancer
2.4.3 Breast?Cancer
2.4.4 Ovarian?Cancer?
2.4.5 Others
2.5 Oncolytic Virus Therapy Market Size by Application
2.5.1 Global Oncolytic Virus Therapy Market Size Market Share by Application (2014-2019)
2.5.2 Global Oncolytic Virus Therapy Market Size Growth Rate by Application (2014-2019)

3 Global Oncolytic Virus Therapy by Players
3.1 Global Oncolytic Virus Therapy Market Size Market Share by Players
3.1.1 Global Oncolytic Virus Therapy Market Size by Players (2017-2019)
3.1.2 Global Oncolytic Virus Therapy Market Size Market Share by Players (2017-2019)
3.2 Global Oncolytic Virus Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Oncolytic Virus Therapy by Regions
4.1 Oncolytic Virus Therapy Market Size by Regions
4.2 Americas Oncolytic Virus Therapy Market Size Growth
4.3 APAC Oncolytic Virus Therapy Market Size Growth
4.4 Europe Oncolytic Virus Therapy Market Size Growth
4.5 Middle East & Africa Oncolytic Virus Therapy Market Size Growth

5 Americas
5.1 Americas Oncolytic Virus Therapy Market Size by Countries
5.2 Americas Oncolytic Virus Therapy Market Size by Type
5.3 Americas Oncolytic Virus Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Oncolytic Virus Therapy Market Size by Countries
6.2 APAC Oncolytic Virus Therapy Market Size by Type
6.3 APAC Oncolytic Virus Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Oncolytic Virus Therapy by Countries
7.2 Europe Oncolytic Virus Therapy Market Size by Type
7.3 Europe Oncolytic Virus Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Oncolytic Virus Therapy by Countries
8.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Type
8.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Oncolytic Virus Therapy Market Forecast
10.1 Global Oncolytic Virus Therapy Market Size Forecast (2019-2024)
10.2 Global Oncolytic Virus Therapy Forecast by Regions
10.2.1 Global Oncolytic Virus Therapy Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Oncolytic Virus Therapy Forecast by Type
10.8 Global Oncolytic Virus Therapy Forecast by Application

11 Key Players Analysis
11.1 Amgen
11.1.1 Company Details
11.1.2 Oncolytic Virus Therapy Product Offered
11.1.3 Amgen Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Amgen News
11.2 Oncolytics Biotech
11.2.1 Company Details
11.2.2 Oncolytic Virus Therapy Product Offered
11.2.3 Oncolytics Biotech Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Oncolytics Biotech News
11.3 Viralytics
11.3.1 Company Details
11.3.2 Oncolytic Virus Therapy Product Offered
11.3.3 Viralytics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Viralytics News
11.4 Transgene SA
11.4.1 Company Details
11.4.2 Oncolytic Virus Therapy Product Offered
11.4.3 Transgene SA Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Transgene SA News
11.5 Oncolys BioPharma
11.5.1 Company Details
11.5.2 Oncolytic Virus Therapy Product Offered
11.5.3 Oncolys BioPharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Oncolys BioPharma News
11.6 Targovax
11.6.1 Company Details
11.6.2 Oncolytic Virus Therapy Product Offered
11.6.3 Targovax Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Targovax News
11.7 PsiOxus Therapeutics
11.7.1 Company Details
11.7.2 Oncolytic Virus Therapy Product Offered
11.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 PsiOxus Therapeutics News
11.8 SillaJen?Biotherapeutics
11.8.1 Company Details
11.8.2 Oncolytic Virus Therapy Product Offered
11.8.3 SillaJen?Biotherapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 SillaJen?Biotherapeutics News
11.9 Sorrento Therapeutics
11.9.1 Company Details
11.9.2 Oncolytic Virus Therapy Product Offered
11.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Sorrento Therapeutics News
11.10 Lokon Pharma
11.10.1 Company Details
11.10.2 Oncolytic Virus Therapy Product Offered
11.10.3 Lokon Pharma Oncolytic Virus Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Lokon Pharma News
11.11 Genelux Corporation
11.12 Vyriad
11.13 TILT Biotherapeutics
11.14 Cold Genesys

12 Research Findings and Conclusion